News
Attorneys
Practice Areas
Print PDF
Amgen v Sandoz: The Biosimilars Saga Continues
October 27, 2015
Life Sciences IP Review
Autumn 2015
Despite the US Court of Appeals for the Federal Circuit's ruling in Amgen v Sandoz, significant uncertainty concerning two key provisions of the BCPIA remains, as Pharmaceutical Practice Group Co-Chairs Steve Coyle and Leslie-Anne Maxwell describe in their article, "Amgen v Sandoz: The Biosimilars Saga Continues" published in Life Sciences IP Review, Autumn 2015 issue.
